Go Pro

Addus HomeCare (ADUS) Competitors

Addus HomeCare logo
$114.52 +0.70 (+0.62%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$113.65 -0.87 (-0.76%)
As of 07/17/2026 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ADUS vs. PACS, BLLN, CELC, RDNT, and SHC

Should you buy Addus HomeCare stock or one of its competitors? MarketBeat compares Addus HomeCare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Addus HomeCare include PACS Group (PACS), Billiontoone (BLLN), Celcuity (CELC), RadNet (RDNT), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Addus HomeCare compare to PACS Group?

PACS Group (NYSE:PACS) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

PACS Group has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.39$191.54M$1.5629.67
Addus HomeCare$1.42B1.50$95.91M$5.4121.17

PACS Group has a beta of -0.08, suggesting that its stock price is 108% less volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

95.4% of Addus HomeCare shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

PACS Group presently has a consensus price target of $50.60, indicating a potential upside of 9.33%. Addus HomeCare has a consensus price target of $131.50, indicating a potential upside of 14.83%. Given Addus HomeCare's higher probable upside, analysts plainly believe Addus HomeCare is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70

In the previous week, PACS Group had 3 more articles in the media than Addus HomeCare. MarketBeat recorded 6 mentions for PACS Group and 3 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.69 beat PACS Group's score of 0.56 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
0 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Addus HomeCare
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare has a net margin of 6.89% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Addus HomeCare 6.89%9.80%7.34%

Summary

Addus HomeCare beats PACS Group on 10 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Billiontoone?

Addus HomeCare (NASDAQ:ADUS) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Addus HomeCare has a net margin of 6.89% compared to Billiontoone's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.89% 9.80% 7.34%
Billiontoone N/A N/A N/A

Addus HomeCare presently has a consensus price target of $131.50, indicating a potential upside of 14.83%. Billiontoone has a consensus price target of $126.00, indicating a potential downside of 3.31%. Given Addus HomeCare's stronger consensus rating and higher probable upside, research analysts plainly believe Addus HomeCare is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.42B1.50$95.91M$5.4121.17
Billiontoone$305.11M19.64$7.45M$0.55236.93

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Billiontoone had 8 more articles in the media than Addus HomeCare. MarketBeat recorded 11 mentions for Billiontoone and 3 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.69 beat Billiontoone's score of 0.53 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Addus HomeCare beats Billiontoone on 12 of the 15 factors compared between the two stocks.

How does Addus HomeCare compare to Celcuity?

Celcuity (NASDAQ:CELC) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Celcuity currently has a consensus target price of $155.18, suggesting a potential upside of 75.58%. Addus HomeCare has a consensus target price of $131.50, suggesting a potential upside of 14.83%. Given Celcuity's stronger consensus rating and higher probable upside, equities analysts clearly believe Celcuity is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70

Addus HomeCare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$177.04M-$3.90N/A
Addus HomeCare$1.42B1.50$95.91M$5.4121.17

Addus HomeCare has a net margin of 6.89% compared to Celcuity's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -244.61% -50.22%
Addus HomeCare 6.89%9.80%7.34%

Celcuity has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

In the previous week, Celcuity had 23 more articles in the media than Addus HomeCare. MarketBeat recorded 26 mentions for Celcuity and 3 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.69 beat Celcuity's score of 0.11 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
8 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral
Addus HomeCare
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Addus HomeCare beats Celcuity on 11 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to RadNet?

RadNet (NASDAQ:RDNT) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

In the previous week, RadNet had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 4 mentions for RadNet and 3 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.69 beat RadNet's score of 0.51 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Addus HomeCare
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.40-$18.65M-$0.18N/A
Addus HomeCare$1.42B1.50$95.91M$5.4121.17

77.9% of RadNet shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

RadNet currently has a consensus target price of $87.43, suggesting a potential upside of 40.58%. Addus HomeCare has a consensus target price of $131.50, suggesting a potential upside of 14.83%. Given RadNet's stronger consensus rating and higher possible upside, research analysts plainly believe RadNet is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.80
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70

Addus HomeCare has a net margin of 6.89% compared to RadNet's net margin of -0.66%. Addus HomeCare's return on equity of 9.80% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.66% 2.77% 0.97%
Addus HomeCare 6.89%9.80%7.34%

RadNet has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

RadNet and Addus HomeCare tied by winning 8 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to Sotera Health?

Addus HomeCare (NASDAQ:ADUS) and Sotera Health (NASDAQ:SHC) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Addus HomeCare has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market. Comparatively, Sotera Health has a beta of 1.76, suggesting that its share price is 76% more volatile than the broader market.

In the previous week, Addus HomeCare had 1 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for Addus HomeCare and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.35 beat Addus HomeCare's score of 0.69 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sotera Health
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare currently has a consensus target price of $131.50, suggesting a potential upside of 14.83%. Sotera Health has a consensus target price of $20.25, suggesting a potential upside of 14.08%. Given Addus HomeCare's higher probable upside, equities analysts clearly believe Addus HomeCare is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

Addus HomeCare has higher revenue and earnings than Sotera Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.42B1.50$95.91M$5.4121.17
Sotera Health$1.16B4.35$77.94M$0.4143.29

Sotera Health has a net margin of 9.91% compared to Addus HomeCare's net margin of 6.89%. Sotera Health's return on equity of 39.73% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.89% 9.80% 7.34%
Sotera Health 9.91%39.73%7.05%

Summary

Sotera Health beats Addus HomeCare on 9 of the 17 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.14B$6.38B$6.88B$12.29B
Dividend YieldN/A1.39%2.67%9.34%
P/E Ratio21.1739.8322.3621.46
Price / Sales1.5039.84526.8891.23
Price / Cash17.6319.7252.9960.41
Price / Book1.953.9610.696.18
Net Income$95.91M$218.81M$3.59B$332.29M
7 Day Performance5.83%3.73%-2.20%-2.05%
1 Month Performance21.53%16.67%1.63%-2.15%
1 Year Performance7.00%43.84%25.59%17.26%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
3.1569 of 5 stars
$114.52
+0.6%
$131.50
+14.8%
+4.4%$2.14B$1.42B21.1750,659
PACS
PACS Group
2.9549 of 5 stars
$44.15
-1.9%
$48.00
+8.7%
+274.6%$6.99B$5.29B28.3047,455
BLLN
Billiontoone
1.8805 of 5 stars
$121.06
-1.9%
$126.00
+4.1%
N/A$5.59B$305.11M221.14620
CELC
Celcuity
3.4459 of 5 stars
$110.92
+2.2%
$152.09
+37.1%
+542.8%$5.41BN/AN/A40
RDNT
RadNet
3.4275 of 5 stars
$68.13
-1.2%
$87.43
+28.3%
+5.7%$5.35B$2.04BN/A11,264

Related Companies and Tools


This page (NASDAQ:ADUS) was last updated on 7/18/2026 by MarketBeat.com Staff.
From Our Partners